Episode Details

Back to Episodes

SGEM#521: Hit Me with Your Best Shot – IM Ketorolac for Back Pain?

Published 1 month, 3 weeks ago
Description
Date: September 22, 2026 Dr. Sergey Motov Guest Skeptic: Dr. Sergey Motov is an Emergency Physician in the Department of Emergency Medicine, Maimonides Medical Center in New York City. He is also one of the world’s leading researchers on pain management in the emergency department.  Reference: Sharabun et al. Oral Ibuprofen Versus Intramuscular Ketorolac for Acute Musculoskeletal Back Pain in the Emergency Department: A Prospective Analysis. Journal of Pharmacy Practice. 2026 Case: A 42-year-old man presents to the emergency department (ED) with three days of severe lower back pain that started after moving boxes at work. There was no fall or direct trauma. He describes constant, non-radiating pain rated 8/10 that is worse with movement and is preventing him from sleeping and returning to work. He denies fever, intravenous drug use, cancer, recent infection, weight loss, leg weakness, saddle anesthesia, or bowel or bladder dysfunction. His vital signs are normal. He has bilateral lumbar paraspinal tenderness, no midline tenderness, and an intact lower-extremity neurologic examination. He has not taken an analgesic or muscle relaxant in the preceding four hours and has no history of kidney disease, peptic ulcer disease, gastrointestinal bleeding, hepatic failure, or NSAID allergy. You diagnose acute atraumatic musculoskeletal back pain and offer oral ibuprofen. He replies that pills never work for him and asks for the Toradol shot because it is stronger. Background: Back pain is one of those emergency department (ED) complaints that can fill the waiting room, empty the medication cupboard, and still leave both the patient and clinician frustrated. Patients commonly present after lifting, twisting, shovelling, moving furniture, or sometimes with no memorable trigger at all. The pain can be severe enough to interfere with walking, sleeping, working, and activities of daily living. Most have no concerning neurologic findings or other red flags, but our first job remains identifying the uncommon patient with fracture, infection, malignancy, cauda equina syndrome, or another serious cause. Once you have considered serious pathology, the next challenge is treatment. Unfortunately, there is no magic analgesic for uncomplicated acute low back pain. Acetaminophen, NSAIDs, corticosteroids, benzodiazepines, skeletal muscle relaxants, opioids, and various medication combinations have all been studied, generally producing small, inconsistent, or clinically unimpressive benefits. Non-pharmacologic approaches, including cognitive behavioural therapy, mindfulness, chiropractic manipulation, physiotherapy, acupuncture, massage, and most recently TENS, have also been tried. Some patients report benefit, but no single treatment has emerged as the reliable winner. The SGEM has returned to this topic repeatedly because low back pain is common, disabling, and stubbornly difficult to treat.  NSAIDs remain a common starting point for eligible ED patients with acute musculoskeletal back pain. Oral ibuprofen is inexpensive, familiar, and easy to administer. Ketorolac is frequently given intravenously or intramuscularly and carries a certain aura of being faster, stronger, or somehow more serious medicine. Patients will sometimes specifically request the injection because they believe it must work better. Route of administration can matter when a patient cannot swallow, is vomiting, must remain nil by mouth, or already has vascular access. However, a parenteral route does not automatically provide superior analgesia. It also comes with additional expense, administration time, injection pain, hematoma risk, and occupational needlestick risk. In 2000, Schwartz and colleagues examined whether the perception of receiving an injection created additional analgesia. Every participant unknowingly received 800 mg of ibuprofen in an orange-flavoured drink and was then randomized to a placebo pill or placebo saline injection. Pain relief was virtually identical b
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us